
Alberto Delaidelli
Articles
-
Sep 30, 2024 |
biorxiv.org | Lin Evlin |Nanna M. Jensen |Sara Ferreira |Alberto Delaidelli
AbstractA pathological role of alpha-Synuclein (aSyn) aggregation in the central nervous system (CNS) is a recognized feature in Parkinson disease (PD) and related neurodegenerative conditions termed synucleinopathies.
-
Mar 8, 2024 |
biorxiv.org | Laura A. Hruby |Katerina Scharov |Alberto Delaidelli |Daniel Picard
AbstractMedulloblastoma (MB) is the most common malignant brain tumor in childhood and is stratified into four molecular groups ‒ WNT, SHH, Group 3 and Group 4. Group 3 MB patients exhibit the poorest prognosis, with a 5-year overall survival of <60%, followed by Group 4 MB patients. Apart from MYC amplification in a subset of Group 3 MBs, the molecular pathomechanisms driving aggressiveness of these tumors remain incompletely characterized.
-
Feb 27, 2024 |
mdpi.com | Alberto Delaidelli |Alessandro Moiraghi
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Jan 18, 2024 |
cell.com | Alberto Delaidelli |Poul H Sorensen
Hofman et al. reveal a novel survival mechanism in high-risk childhood medulloblastoma through the translation of non-canonical open reading frames (ORFs). The study uncovers the critical role of these often-overlooked ORFs, particularly the ASNSD1-uORF, in medulloblastoma cell survival, offering new avenues for targeted therapies in pediatric cancer.
-
May 15, 2023 |
mdpi.com | Betty Yao |Alberto Delaidelli |Hannes Vogel |Poul H Sorensen
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessReviewbyBetty Yao 1, Alberto Delaidelli 1,2, Hannes Vogel 3 and Poul H.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →